Mirati Therapeutics Inc: Patents

View up-to-date information on Mirati Therapeutics Inc patents, including inventor and filing insights.

Patent Trends

Publication Identifier	Document Type	Title	Classification-CPC	Publication Date
WO2022192507A1	Application	CRYSTALLINE SALT OF A MULTI-TYROSINE KINASE INHIBITOR, METHOD OF PREPARATION, AND USE THEREOF	C07B2200/13; C07D495/04	September 15, 2022
WO2022192745A1	Application	MTA-COOPERATIVE PRMT5 INHIBITORS	A61P31/00; A61P43/00; C07D401/10; C07D401/14; C07D403/10; C07D405/14; C07D409/14; C07D413/14; C07D471/04; C07D495/04	September 15, 2022
US20220274990A1	Application	IMIDAZO[1,2-C]PYRIMIDINE DERIVATIVES AS PRC2 INHIBITORS FOR TREATING CANCER	C07D487/04	September 01, 2022
EP4043466A1	Application	PRC2-INHIBITOREN	A61K31/519; A61P35/00; C07D487/04	August 17, 2022
EP3880208A4	Search Report	KRAS-G12C-INHIBITOREN	A61K31/519; A61K31/5355; A61K31/5377; A61P35/00; C07D471/04; C07D491/08	August 17, 2022

Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Contact Us

Name	Count

Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Contact Us

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer